Topic: Life Sciences & Medicine

  • News

    A gut-on-chip device for personalised health solutions

    The University and spin-off NIUM are reinforcing their relationship by signing a second license agreement, through which NIUM will further develop and use MicroGut technology, an in vitro gut-on-a-chip device conceived at University’s Luxembourg Centre for Systems Biomedicine, which emulates the human gastrointestinal tract on a chip, for testing the impact of food products and…

    Learn more
  • News

    Discover new study programmes for the 2024-2025 academic year

    The University of Luxembourg is expanding and fine-tuning its academic offer, with the launch of six new programmes and the redesigning of three existing ones.

    Learn more
  • News

    Three Uni.lu professors on the Highly Cited Researchers 2023 list

    Prof. Michael Heneka, Prof. Alexandre Tkatchenko and Prof. Paul Wilmes have been selected on the Highly Cited Researchers 2023 list by Clarivate, for “demonstrating significant and broad influence in their field(s) of research”.

    Learn more
  • News

    Hands-on discoveries and workshops at the Science Festival

    From 9 to 12 November 2023, the University of Luxembourg will participate in the Science Festival, with seven workshops in Luxembourg-Grund in the National Museum of Natural History and in the Neumünster Abbey. The first two days will be reserved for registered school classes and groups, while the last two will be opened for the…

    Learn more
  • News

    Uni and CHL strengthen their partnership in teaching and research

    On 19 and 20 October 2023, the management bodies of the University of Luxembourg and the Centre Hospitalier de Luxembourg (CHL) further consolidated their collaboration by signing a framework agreement for scientific and educational cooperation, with the goal of providing university courses in medicine and the health professions.

    Learn more
  • News

    Ground-breaking discovery for diagnosing neurodegenerative diseases

    An international team consisting of researchers from Japan and Luxembourg showed for the first time that pathological forms of the alpha-synuclein protein present in the blood of patients can be used for the diagnosis of Parkinson’s disease and its differentiation from several other neurodegenerative motor disorders.

    Learn more
  • News

    COVID-19 Task Force awarded the 2022 Science for Society Prize

    The 2022 Science for Society Prize, an initiative of the Science for Society Foundation, under the aegis of Fondation de Luxembourg, has been awarded to the Research Luxembourg COVID-19 Task Force, represented by Prof. Paul Wilmes from the University of Luxembourg. The COVID-19 Task Force, a collective effort between several Luxembourg research institutions regrouped under…

    Learn more
  • News

    Gaining unprecedented view of small molecules by machine learning

    A new tool to identify small molecules offers benefits for diagnostics, drug discovery and fundamental research.

    Learn more
  • News

    How damaged cells inhibit muscle regeneration over lifetime

    Humans have a limited capacity for self-regeneration of tissues and organs but they do keep a pool of stem cells throughout their life that can self-renew and differentiate into specific cell types. These stem cells are widely studied as they could enable the repair of human tissues and thus have great potential for medicine. On…

    Learn more